|View printer-friendly version|
|Idera Pharmaceuticals Announces Presentation at American Academy of Dermatology Annual Meeting|
The details of the presentation are as follows:
Title: Novel Toll-Like Receptor Antagonists Strongly Decrease Expression of IL-23-induced and Psoriasis Profile Genes in a Mouse Model
Session: Late Breaking Research Symposium
Idera Forward Looking Statements
This press release contains forward-looking statements concerning
Idera Pharmaceuticals, Inc.